Anti-Human CD45RO FITC

Grouped product items
Size Price Qty
25 tests
$70.00
100 tests
$115.00

Additional UCHL1 Formats

Cat.No. Format Starting From
07141-60 PE $ 80.00
07141-20 Purified $ 75.00
07141-50 FITC $ 70.00
07141-80 APC $ 100.00
07141-70 PerCP-Cyanine5.5 $ 135.00
07141-30 Biotin $ 145.00
Catalog Number : 07141-50

description

The UCHL1 monoclonal antibody specifically reacts with human CD45RO, a 180 kDa isoform of the leukocyte common antigen CD45. CD45RO is a transmembrane glycoprotein with tyrosine phosphatase activity and is expressed by majority of thymocytes, monocytes, granulocytes, and activated memory T lymphocytes. The subsets of peripheral T lymphocytes can be discriminated by using the CD45RO and CD45RA expressing cells.

product image
Human peripheral blood lymphocytes were stained with FITC UCHL1 with relevant isotype control in Red.

Additional Information

Clone:
UCHL1
Format:
FITC
Applications:
FC
Reactivity:
Human
Isotype:
Mouse IgG2a, kappa
Research Interest: Adaptive Immunity
Cell Type: B Cells, Macrophage / Monocyte, T Cells
Application: FC
Clone: UCHL1
Protein Cross Reactivity: Chimpanzee
Preparation:
The product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.
Formulation:
Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.
References:

Knapp W (1989) Leucocyte typing IV: white cell differentiation antigens. Oxford University Press, 1989.

Akbar, A. N., Terry, L., Timms, A., Beverley, P. C., & Janossy, G. (1988). Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. The Journal of Immunology140(7), 2171-2178.

Smith, S. H., Brown, M. H., Rowe, D., Callard, R. E., & Beverley, P. C. (1986). Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology58(1), 63.

© BioGems International, Inc. All rights reserved.